NO20070931L - Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje. - Google Patents

Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje.

Info

Publication number
NO20070931L
NO20070931L NO20070931A NO20070931A NO20070931L NO 20070931 L NO20070931 L NO 20070931L NO 20070931 A NO20070931 A NO 20070931A NO 20070931 A NO20070931 A NO 20070931A NO 20070931 L NO20070931 L NO 20070931L
Authority
NO
Norway
Prior art keywords
polyclonal
cell line
structural characterization
recombinant
protein
Prior art date
Application number
NO20070931A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Sejer Andersen
Soren Kofoed Rasmussen
Lone Kjaer Rasmussen
Torben Frandsen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Publication of NO20070931L publication Critical patent/NO20070931L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Document Processing Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20070931A 2004-07-20 2007-02-19 Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje. NO20070931L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22
PCT/DK2005/000504 WO2006007853A2 (en) 2004-07-20 2005-07-20 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line

Publications (1)

Publication Number Publication Date
NO20070931L true NO20070931L (no) 2007-04-17

Family

ID=35427551

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070931A NO20070931L (no) 2004-07-20 2007-02-19 Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje.

Country Status (19)

Country Link
US (2) US8288109B2 (ru)
EP (2) EP2053408B1 (ru)
JP (1) JP4870667B2 (ru)
KR (1) KR101319848B1 (ru)
AT (2) ATE548657T1 (ru)
AU (1) AU2005263334C1 (ru)
BR (1) BRPI0513714A (ru)
CA (1) CA2574146C (ru)
DE (1) DE602005016818D1 (ru)
DK (2) DK1787126T3 (ru)
ES (2) ES2332524T3 (ru)
HK (2) HK1101043A1 (ru)
IL (2) IL180169A (ru)
MX (1) MX2007000551A (ru)
NO (1) NO20070931L (ru)
NZ (1) NZ552264A (ru)
PL (2) PL2053408T3 (ru)
RU (1) RU2426795C2 (ru)
WO (1) WO2006007853A2 (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762617A1 (en) 2003-01-07 2007-03-14 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
NZ552264A (en) 2004-07-20 2010-03-26 Symphogen As A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
CA2574062A1 (en) 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
CA2676049C (en) * 2007-03-01 2018-04-10 Symphogen A/S Recombinant anti-epidermal growth factor receptor antibody compositions
SI2121920T1 (sl) * 2007-03-01 2011-12-30 Symphogen As Postopek za kloniranje sorodnih protiteles
CA2678628A1 (en) * 2007-03-06 2008-09-12 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
EP2139509A2 (en) * 2007-03-15 2010-01-06 Biogen Idec MA, Inc. Treatment of autoimmune disorders
CN101688204B (zh) 2007-05-25 2013-07-03 西福根有限公司 用于制造重组多克隆蛋白质的方法
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
RU2010113510A (ru) * 2007-09-07 2011-10-20 Симфоген А/С (Dk) Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv)
NZ584684A (en) 2007-11-22 2012-10-26 Symphogen As A method for characterization of a recombinant polyclonal protein
SG189793A1 (en) * 2008-04-23 2013-05-31 Symphogen As Methods for manufacturing a polyclonal protein
AU2009287163B2 (en) 2008-08-29 2014-11-13 Les Laboratoires Servier Recombinant anti-Epidermal Growth Factor Receptor antibody compositions
KR20110058861A (ko) * 2008-08-29 2011-06-01 심포젠 에이/에스 조류 유래 항체의 클로닝 방법
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
CA2776508A1 (en) * 2009-10-09 2011-04-14 Symphogen A/S Multiplex quantitation of individual recombinant proteins in a mixture by signature peptides and mass spectrometry
WO2011130377A2 (en) * 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
ES2616961T3 (es) 2010-11-01 2017-06-14 Symphogen A/S Composición de anticuerpos pan-HER
US9790269B2 (en) 2013-02-08 2017-10-17 Misfolding Diagnostics, Inc. Transthyretin antibodies and uses thereof
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Método de producción de anticuerpos específicos
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子（ｍｃａｍ）抗體類及使用彼等之相關方法
EP3497444A4 (en) * 2016-08-12 2020-11-11 Abreos Biosciences, Inc. DETECTION AND QUANTIFICATION OF NATALIZUMAB
CA3104390A1 (en) * 2018-06-22 2019-12-26 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯（重庆）医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002413A1 (en) 1983-11-28 1985-06-06 The Board Of Trustees Of The Leland Stanford Jr. U HUMAN MONOCLONAL ANTIBODY AGAINST Rh(D) ANTIGEN AND ITS USES
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5126130A (en) 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
DE68913658T3 (de) 1988-11-11 2005-07-21 Stratagene, La Jolla Klonierung von Immunglobulin Sequenzen aus den variablen Domänen
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
CA2116246A1 (en) 1992-06-26 1994-01-06 Roland Beliard Human monoclonal anti-rhesus (d) antibodies and cell lines producing same
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
AU1736495A (en) * 1994-01-31 1995-08-15 Trustees Of Boston University Polyclonal antibody libraries
FR2724182B1 (fr) 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
PL186019B1 (pl) 1996-06-24 2003-09-30 Zlb Bioplasma Ag Polipeptydy zdolne do tworzenia struktur wiążących antygen o swoistości względem antygenów Rh D, sekwencje DNA kodujące te polipeptydy oraz sposób ich wytwarzania i stosowania
US6255455B1 (en) 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
JP4128227B2 (ja) 1997-03-14 2008-07-30 バイオジェン・アイデック・インコーポレイテッド 哺乳類細胞内の特定部位に相同組換えによって遺伝子を組み込む方法とそれを実施するためのベクター
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
WO2000011155A1 (en) 1998-08-19 2000-03-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
WO2001006233A1 (en) * 1999-07-16 2001-01-25 Human Genome Sciences, Inc. Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy
DK1234022T3 (da) 1999-07-23 2010-07-19 Univ California DNA-rekombination i eukaryote celler med bakteriofag PHIC31-rekombinationssystemet
EP1106625A1 (en) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
CA2401663C (en) 2000-02-08 2008-11-25 The Regents Of The University Of Michigan Protein mapping
MXPA02007664A (es) 2000-02-08 2004-08-23 Univ Michigan Separacion y representacion de proteinas.
EP1256001A2 (en) 2000-02-08 2002-11-13 The Regents Of The University Of Michigan Mapping of differential display of proteins
AU6206701A (en) 2000-05-26 2001-12-03 Symphogen As Recombinant or purified polyclonal antibodies for treating allergy
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
AU2002239369A1 (en) 2000-11-28 2002-06-11 Applied Molecular Evolution, Inc. Eukaryotic expression libraries based on double lox recombination and methods of use
DE60142650D1 (de) 2000-12-26 2010-09-02 Inst Systems Biology Seattle Schnelle und quantitative Proteomanalyse und entsprechende Verfahren
US7541003B2 (en) * 2001-07-17 2009-06-02 Bio-Rad Laboratories, Inc. Latex based adsorbent chip
JP4767496B2 (ja) * 2001-12-08 2011-09-07 マイクロマス ユーケー リミテッド マススペクトル測定方法
AU2003237282A1 (en) 2002-05-31 2003-12-19 The Regents Of The University Of Michigan Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
ES2442615T5 (es) * 2002-07-18 2023-03-16 Merus Nv Producción recombinante de mezclas de anticuerpos
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi ２次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
US20040137526A1 (en) 2002-10-15 2004-07-15 The Regents Of The University Of Michigan Multidimensional protein separation system
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
EP1762617A1 (en) * 2003-01-07 2007-03-14 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
NZ552264A (en) 2004-07-20 2010-03-26 Symphogen As A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
CA2574062A1 (en) 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
MX2008011280A (es) 2006-03-06 2008-09-12 Symphogen As Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio.
NZ584684A (en) 2007-11-22 2012-10-26 Symphogen As A method for characterization of a recombinant polyclonal protein

Also Published As

Publication number Publication date
IL203017A (en) 2013-08-29
RU2007106050A (ru) 2008-08-27
ES2332524T3 (es) 2010-02-08
IL180169A (en) 2011-04-28
JP4870667B2 (ja) 2012-02-08
PL2053408T3 (pl) 2012-08-31
AU2005263334A1 (en) 2006-01-26
DK2053408T3 (da) 2012-06-04
EP1787126B1 (en) 2009-09-23
US20130203063A1 (en) 2013-08-08
WO2006007853A2 (en) 2006-01-26
US8288109B2 (en) 2012-10-16
ES2381531T3 (es) 2012-05-29
BRPI0513714A (pt) 2008-05-13
EP2053408A2 (en) 2009-04-29
EP2053408A3 (en) 2009-07-29
US20080131882A1 (en) 2008-06-05
ATE443870T1 (de) 2009-10-15
RU2426795C2 (ru) 2011-08-20
DK1787126T3 (da) 2009-12-21
HK1101043A1 (en) 2007-10-05
CA2574146A1 (en) 2006-01-26
KR20070032078A (ko) 2007-03-20
HK1133076A1 (en) 2010-03-12
PL1787126T3 (pl) 2010-03-31
DE602005016818D1 (de) 2009-11-05
EP2053408B1 (en) 2012-03-07
AU2005263334C1 (en) 2011-01-20
AU2005263334B2 (en) 2010-08-05
KR101319848B1 (ko) 2013-10-18
CA2574146C (en) 2015-06-30
US9029091B2 (en) 2015-05-12
JP2008506960A (ja) 2008-03-06
EP1787126A2 (en) 2007-05-23
WO2006007853A3 (en) 2006-05-18
ATE548657T1 (de) 2012-03-15
MX2007000551A (es) 2007-03-30
NZ552264A (en) 2010-03-26
IL180169A0 (en) 2007-06-03

Similar Documents

Publication Publication Date Title
NO20070931L (no) Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje.
Sander et al. A new method to bind allergens for the measurement of specific IgE antibodies
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
EA200700751A1 (ru) Способы и композиции для улучшения продуцирования рекомбинантного белка
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
NZ701825A (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
DE602005013947D1 (de) Antikörper gegen hundepankreaslipase
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
Kosmoliaptsis et al. Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera
CN109596839A (zh) 人和肽素快速定量检测方法与试剂盒
Wang et al. Development of antibody arrays for monoclonal antibody higher order structure analysis
Rutkowski et al. Isolation and quantitation of adiponectin higher order complexes
DE602005022757D1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
DE69835047D1 (de) Schaumproteine, monoklonale Antikörper dagegen, und deren Verwendungen
SE0003566D0 (sv) A method for the quantitative determination of one or more compounds
Timbrell et al. An immunodiagnostic assay for quantitation of specific IgE to the major pollen allergen component, Pas n 1, of the subtropical Bahia grass
Mehand et al. Estimation of analyte concentration by surface plasmon resonance-based biosensing using parameter identification techniques
Huang et al. Synergistic actions of histamine-releasing factor and histamine releasing factor-reactive IgE in chronic urticaria
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
ATE423133T1 (de) Verfahren und materialien zur behandlung von entzündungen unter verwendung eines polypeptides das einen eigenen-c5 aminosaüresegment und einen nicht-eigenen aminosaüresegment enthält
Altinier et al. An IgE multiple myeloma: contradictory findings in clinical laboratory testing
WO2007089563A3 (en) Rabbit monoclonal antibodies against mouse/human id3 proteins
Kelner et al. Analytical strategy for biopharmaceutical development

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application